Le Zhang, PhD Wins Avenir Award for Research on Substance Use Disorders and HIV/AIDS
Assistant Professor Le Zhang, PhD was recently awarded a DP2 grant from the National Institutes of Health (NIH), entitled “Immune Network Dysregulation of the Central Nervous System with HIV Persistence and Opioid Abuse.” The grant, which amounts to more than $2.5 million, began on May 15, 2022 and lasts for four years.
$15M NIDA Grant Awarded to Serena Spudich, Mark Gerstein, and Yuval Kluger
Principal Investigators Serena Spudich, MD, MA (Neurology), Mark Gerstein, PhD (Molecular Biophysics and Biochemistry), and Yuval Kluger, PhD (Pathology) were recently awarded a $15 million grant from the National Institute on Drug Abuse (NIDA) to establish a Data Center to coordinate, analyze, and make accessible single-cell and other molecular data sets generated by Single-Cell Opioid Responses in the Context of HIV (SCORCH) and other NIDA-funded HIV and substance use disorder projects.
Saving Lives: YSPH students receive training on overdose response
On February 9th, 2023, 91 Yale School of Public Health students gathered in Winslow Auditorium for training on overdose prevention and response. Overdose training is considered an important skill for future public health practitioners and community workers.
Why 25? Doctors warn against the negative impact of cannabis use on young adult brains
Cannabis is now decriminalized in Connecticut for people 21 and older. Drs. Deepa Camenga & Deepak (Cyril) D'Souza speak on the risks and implications of recreational cannabis use before the age of 25.Source: Connecticut Public Radio
Six CT toddlers died from Fentanyl in 2021. Its potency and a spike in illicit use have child advocates worried what’s to come.
Dr. Deepa Camenga, associate professor of emergency medicine, pediatrics and public health at the Yale School of Medicine, shares how children and teens find themselves coming in contact with fentanyl as accidental overdoses rise.Source: Hartford Courant
Survey Shows Most Physicians Favor Allowing Telehealth to Treat Opioid-use Disorder
A survey of more than 1,000 registered physicians who used telehealth services to treat patients with opioid-use disorder during COVID-19 found that an overwhelming majority favor making telehealth a permanent part of their practice.
De Aquino Awarded IMPOWR-YOU Grant to Study Pain Sensitivity, Opioid Use Disorder
Joao P. De Aquino, MD, assistant professor of psychiatry, has been awarded a pilot grant from the Integrative Management of Chronic Pain and Opioid Use Disorder for Whole Recovery-Yale and Organizations United (IMPOWR-YOU) Research Center to evaluate the relationship between pain sensitivity and brain synaptic density among people with opioid use disorder (OUD).
Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study
COVID-19 patients with substance use disorders had greater likelihood of requiring critical interventions, such as ICU admission and ventilatory support. Substance use disorders and psychiatric diagnoses were also associated with a longer duration of hospitalization and greater number of hospital admissions.Source: The Journal of Clinical Psychiatry
A call to prioritize substance use treatment in children
While nearly 6 million adolescents and young adults in the United States have a substance use disorder, only 8% receive treatment, according to data collected in 2019. This treatment gap is a critical problem, says Deepa Camenga, associate professor of emergency medicine at Yale School of Medicine and associate director of pediatric programs for the Yale Program in Addiction Medicine.Source: Yale News
Yale Scientists Identify Genetic Risk Factors for Opioid Use and Related Substance Use Disorders
A new human genomics study led by Yale scientists has identified genetic risk factors for opioid use disorder (OUD) and related substance use disorders according to a new large-scale genome-wide association study – increasing the number of risk genes known from 1 to 19.
Patients with Opioid Use Disorder Treated in Emergency Departments Shed Light on Their Unmet Needs and Opportunities to Improve Care in Yale-Led Study Published in JAMA Network Open
To better understand the experiences of patients with OUD on receiving care in the ED and to identify opportunities to improve care, Yale researchers led a collaboration with New York University, John’s Hopkins University, University of Cincinnati, Mount Sinai Hospital in New York, and the University of Washington. Between June 2018 and January 2019. They conducted focus groups with ED patients across six academic, community, and public safety net EDs in Baltimore, MD, Cincinnati, OH, New York City, NY, Seattle, WA and Claremont, NH, as part of two NIDA Clinical Trials Network studies.